What question did this study set out to answer?

This research aims to compare the clinical and microbiological characteristics of ventilator-associated pneumonia (VAP) in COVID-19 and non-COVID-19 patients.

March 30, 2026Open Access

Ventilator-associated pneumonia in an intensive care unit: A comparative analysis of clinical and microbiological characteristics of COVID-19 and non-COVID-19 patients

Puntos clave

This research aims to compare the clinical and microbiological characteristics of ventilator-associated pneumonia (VAP) in COVID-19 and non-COVID-19 patients.
Comparative analysis of clinical data from COVID-19 and non-COVID-19 patients in an intensive care unit.
Assessment of microbiological characteristics associated with VAP.
Evaluation of treatment interventions including corticosteroid use.
COVID-19 patients exhibit higher rates of acute respiratory distress syndrome (ARDS) and corticosteroid treatment.
COVID-19-associated VAP shows a greater prevalence of multidrug-resistant organisms compared to non-COVID-19 cases.
Individualized antimicrobial strategies are suggested to reduce morbidity and mortality.

Resumen

COVID-19 is a significant risk factor for VAP, with distinct clinical and microbiological characteristics compared to non-COVID-19 VAP. The greater occurrence of ARDS, corticosteroid use, and multidrug-resistant organisms in COVID-19-associated VAP highlights the urgent need for individualized antimicrobial strategies aimed at reducing infection-related morbidity and mortality.

Me gusta

Guardar

Ver artículo completo

Cite This Study

Saricaoglu et al. (Wed,) studied this question.

synapsesocial.com/papers/69ca134b883daed6ee095338 https://doi.org/https://doi.org/10.5578/tt.2026011187

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

Me gusta

Guardar

Ver artículo completo